Psychedelic Business Spotlight: July 16, 2021
Business, Stock Reports
This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.
Thanks James for your overview and perspective. IMO the psychedelic medicine industry will succeed, because of the need for more effective approaches. Do you or anybody on this thread believe consolidation through mergers and acqusitions are a near term possibility to help cash strapped startups contribute their IP to the furthering possibility of commercialization and availability of these drugs?